Literature DB >> 3169729

Occlusive hypertrophic arteritis as the cause of discrete necrosis in CNS toxoplasmosis in the acquired immunodeficiency syndrome.

T E Huang1, S M Chou.   

Abstract

Brain specimens from five immunocompromised patients with CNS toxoplasmosis were studied with immunostaining for toxoplasma antigens and electron microscopy. The tachyzoites or toxoplasma antigens were predominantly localized in walls of hypertrophic, often thrombosed, arteries and adjacent brain tissue at the hyperemic rims of centrally necrotic lesions. This study suggests that in CNS toxoplasmosis of immunocompromised hosts, the organisms primarily invade and spread along segments of small artery walls, causing hypertrophy of arterial walls, thrombotic occlusion of lumens, circumscribed but expansive ischemic necrosis, and extravasation of organisms. Rapid response to chemotherapy can be explained by this preferential parasitism to the arterial walls. Early definitive diagnosis on brain biopsy specimens can be attained by immunostaining.

Entities:  

Mesh:

Year:  1988        PMID: 3169729     DOI: 10.1016/s0046-8177(88)80153-9

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  3 in total

1.  Diffuse "encephalitic" cerebral toxoplasmosis in AIDS. Report of four cases.

Authors:  F Gray; R Gherardi; E Wingate; J Wingate; G Fénelon; A Gaston; A Sobel; J Poirier
Journal:  J Neurol       Date:  1989-07       Impact factor: 4.849

2.  Pineal toxoplasmosis mimicking pineal tumor in an AIDS patient.

Authors:  T P Poon; M Behbahani; I Matoso; B Kim
Journal:  J Natl Med Assoc       Date:  1994-07       Impact factor: 1.798

3.  Placental thrombosis in acute phase abortions during experimental Toxoplasma gondii infection in sheep.

Authors:  Pablo Castaño; Miguel Fuertes; Ignacio Ferre; Miguel Fernández; Maria del Carmen Ferreras; Javier Moreno-Gonzalo; Camino González-Lanza; Frank Katzer; Javier Regidor-Cerrillo; Luis Miguel Ortega-Mora; Valentín Pérez; Julio Benavides
Journal:  Vet Res       Date:  2014-01-29       Impact factor: 3.683

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.